Table 4.
Regional and geographic variation in endemic fluoroquinolone resistance (%) among ocular pathogens
| Region | Fluoroquinolone
|
Reference | ||||
|---|---|---|---|---|---|---|
| Ciprofloxacin | Gatifloxacin | Moxifloxacin | Number of Isolates | Time Period | ||
| Europe | 12.4 | 5.5 | ND | 532 | July 2001–Dec 2002 | Morrissey et al 2004 |
| France | 12.4 | 5.6 | ND | |||
| Germany | 4.6 | 1.5 | ND | |||
| Italy | 19.9 | 4.6 | ND | |||
| Spain | 15.9 | 9.8 | ND | |||
| Sweden | 2.0 | 0 | ND | |||
| UK | 8.3 | 8.3 | ND | |||
| USA (Northeast) | 28.3 | 13.7 | 20 | 350 | 1993–2005 | Mather et al 2002; Kowlaski et al 2003; Kowalski et al 2005 |
| USA (South Florida) | 30.1 | 16.7 | 23.3 | 431 | 2000–2006 | Miller 2006 (unpublished) |
| Brazil | 14.2 | 11.9 | 11.9 | 183 | 2002–2004 | Oliveira et al 2007 |
ND=Not done.